Minder®: Bridging monitoring gaps in epilepsy patient care
The Minder® system offers the possibility of addressing the shortcomings of current epilepsy diagnostic technology through:
- High quality signal capture;
- Actionable information regarding seizures and other EEG events; and
- A materially extended monitoring window, moving from days to months or years of data.
By enabling more timely and effective treatment, the Minder system has the potential to significantly improve the quality of life for people with epilepsy and have a favourable impact on healthcare costs.
Years-long continuous monitoring
In the US, the device is labelled for use of up to three years, and there is already a track record in multiple patients of use of over five years in Australia. This is materially longer than current standard EEG modalities, which typically have monitoring windows ranging from minutes and hours to days and weeks.
High-quality signal
As demonstrated in the UMPIRE study, data generated by the Minder system was equivalent in signal quality to that collected using a 10‑20 system scalp EEG, including detecting disparate seizure sources (allowing for assessment of both focal and generalised epilepsy) and identifying interictal epileptiform activity (abnormal electrical activity in the brain which can indicate potential for seizures), including during sleep
Remote monitoring
Minder includes secure cloud-based access for healthcare professionals, enabling remote care and regular clinical assessment without requiring patients to visit medical facilities.
First FDA-authorised* iCEM® system
Providing unprecedented long-term epilepsy insights through continuous sub-scalp monitoring that captures what traditional EEGs miss.
The Minder System
The Minder system is a minimally invasive device with equivalent form factors to a cochlear hearing device.
Minder Implant
The Minder Implant is a device placed under the scalp with several electrodes placed under the scalp, across the back of the head—this enables bilateral monitoring. The implant is placed under the scalp behind the ear. These electrodes connect to a small transmitter that's also implanted, which wirelessly sends the brain activity data through the skin to the Wearable.
Minder Wearable
The Minder Wearable receives and stores EEG recordings wirelessly transmitted from the Minder Implant, then transfers this data wirelessly via low power Bluetooth (BLE) to the Minder App, running on a smartphone. It is powered by a rechargeable battery.
Minder App
The Minder App collects and transmits EEG data from the Minder Wearable via Bluetooth and uploads it to Minder Cloud for secure storage and processing. It can also record entries for a patient's seizure diary.
Minder Cloud
Minder Cloud offers a secure online portal that allows healthcare professionals to access and download patient data for viewing.
Minder is the first FDA-authorised* implantable continuous EEG monitoring (iCEM) device
The Minder System is an electroencephalographic (EEG) recording and transmitting device implanted under the scalp. It is a prescription device indicated to acquire, transmit, and store EEGs continuously from patients between 18-75 years of age with drug-resistant epilepsy who are intolerant or not indicated for more conservative monitoring tools. The Minder System is intended to aid in a physician's remote assessment and monitoring of the indicated patient's condition. Remote patient assessment and monitoring for this use is defined as the patient's EEG data is available for review by a healthcare provider located at a different location from the patient and where the data is being collected.
The medical use of the data acquired by the Minder System is to be performed under the direction and interpretation of a licensed medical professional. The Minder System does not provide any diagnostic conclusions about the patient's condition.
Proven safety and effectiveness of Minder
The UMPIRE clinical study confirmed that the Minder System is both safe and effective for patients. With a high acceptance rate, it provides valuable insights into brain activity.
Reliable platform
The Minder® system leverages proprietary hardware and software developed in partnership with Cochlear, combining leading expertise in implantable neurotechnology with advanced signal processing.
The UMPIRE study demonstrated that implantation of the Minder system is a minimally invasive and a straightforward surgical procedure. The procedure to place the device is similar to that for a cochlear hearing device, with the main differences being that, with the Minder system, the electrode is positioned across the head and there is no drilling into the cochlea.
Signal quality
Signal quality shown to be equivalent to 10-20 scalp EEG.
Effective insights
Minder delivered meaningful and actionable clinical insight for ~88% of patients in the UMPIRE study.
Usability validation
90% of participants rated the Minder system's ease of use as neutral to very easy at 24 weeks post‑implant during the UMPIRE study.
Important information
- The Minder System does not provide diagnostic conclusions
- Use of the Minder System must be under the direction of a licensed medical professional